Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses

Circulation

Volumn 124, Issue 11 SUPPL. 1, 2011, Pages

  Lobato, Robert L ^a,b   White, William D ^b   Mathew, Joseph P ^b   Newman, Mark F ^b,c   Smith, Peter K ^b   McCants, Charles B ^c   Alexander, John H ^b,c   Podgoreanu, Mihai V ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

cohort studies; coronary artery bypass grafting; genetic association analysis; longitudinal studies; thoracic surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THROMBOMODULIN;

ADULT; ALLELE; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG USE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL MORTALITY;

AGED; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOMODULIN; TREATMENT OUTCOME;

EID: 80052745584     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.008334     Document Type: Article

References (26)

1. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, Wyse RK, Ferguson TB. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22:101-105. (Pubitemid 34743720)
2. Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J. 2006;27:867-874.
3. De Maria R, Mazzoni M, Parolini M, Gregori D, Bortone F, Arena V, Parodi O. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart. 2005;91:779-784. (Pubitemid 40769225)
4. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115:2878-2901. (Pubitemid 46869676)
5. Muehlschlegel JD, Liu KY, Perry TE, Fox AA, Collard CD, Shernan SK, Body SC. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation. 2010;122:S60-S65.
6. Volzke H, Engel J, Kleine V, Schwahn C, Dahm JB, Eckel L, Rettig R. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest. 2002;122:31-36. (Pubitemid 34754139)
7. Zotz RB, Klein M, Dauben HP, Moser C, Gams E, Scharf RE. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PlA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thromb Haemost. 2000;83:404-407. (Pubitemid 30148352)
8. Kubisz P, Stasko J, Hollý P, Ivanková J, Pullmann R. More on: thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost. 2005;3:2825-2827. (Pubitemid 41819820)
9. Ruel M, Bianchi C, Khan TA, Xu S, Liddicoat JR, Voisine P, Araujo E, Lyon H, Kohane IS, Libermann TA, Sellke FW. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg. 2003;126:1521-1530. (Pubitemid 37449182)
10. Tomic V, Russwurm S, Moller E, Claus RA, Blaess M, Brunkhorst F, Bruegel M, Bode K, Bloos F, Wippermann J, Wahlers T, Deigner HP, Thiery J, Reinhart K, Bauer M. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation. 2005;112:2912-2920. (Pubitemid 41612292)
11. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
12. Hoh J, Wille A, Zee R, Cheng S, Reynolds R, Lindpaintner K, Ott J. Selecting SNPs in two-stage analysis of disease association data: a model-free approach. Ann Hum Genet. 2000;64:413-417. (Pubitemid 32055732)
13. Good PI. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. New York, NY: Springer; 2000.
14. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172, discussion 207-112. (Pubitemid 351193639)
16. Esmon C. Do-all receptor takes on coagulation, inflammation. Nat Med. 2005;11:475-477. (Pubitemid 40685966)
17. Weiler H. Mouse models of thrombosis: thrombomodulin. Thromb Haemost. 2004;92:467-477. (Pubitemid 39248003)
18. Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:345-357.
19. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation. 2004;109:1343-1348. (Pubitemid 38387818)
20. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) study: a case-cohort study. Lancet. 1999;353:1729-1734. (Pubitemid 29240370)
21. Wu KK, Aleksic N, Ballantyne CM, Ahn C, Juneja H, Boerwinkle E. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation. 2003;107:1729-1732. (Pubitemid 36418351)
22. Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation. 2001;103:1386-1389. (Pubitemid 32220629)
23. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA. Thrombomodulin gene mutations associated with myocardial infarction. Circulation. 1997;96:15-18. (Pubitemid 27298395)
24. Auro K, Alanne M, Kristiansson K, Silander K, Kuulasmaa K, Salomaa V, Peltonen L, Perola M. Combined effects of thrombosis pathway gene variants predict cardiovascular events. PLoS Genet. 2007;3:e120.
25. Sugiyama S, Hirota H, Kimura R, Kokubo Y, Kawasaki T, Suehisa E, Okayama A, Tomoike H, Hayashi T, Nishigami K, Kawase I, Miyata T. Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population. Thromb Res. 2007;119:35-43. (Pubitemid 44716204)
26. Tsai CS, Tsai YT, Lin CY, Lin TC, Huang GS, Hong GJ, Lin FY. Expression of thrombomodulin on monocytes is associated with early outcomes in patients with coronary artery bypass graft surgery. Shock. 2010;34:31-39.